Hypothyroidism for USMLE Step 1 & Step 2 CK

High-yield review of hypothyroidism for USMLE Step 1 & Step 2 CK: causes, lab patterns, Hashimoto thyroiditis, myxedema coma, diagnosis, and levothyroxine therapy.

Why Hypothyroidism Matters for the USMLE

Hypothyroidism is one of the most common endocrine disorders and a frequent topic on **USMLE Step 1** and **USMLE Step 2 CK**. It affects nearly every organ system because thyroid hormone regulates basal metabolic rate and β-adrenergic receptor expression.

For exam purposes, you must be able to:

• Distinguish **primary vs. secondary vs. tertiary (central)** hypothyroidism using lab patterns.
• Recognize **Hashimoto thyroiditis** and its autoantibodies.
• Identify classic **clinical manifestations** and systemic effects.
• Diagnose and manage **myxedema coma**, a life-threatening emergency.
• Understand how to **monitor and adjust levothyroxine therapy**.

This guide walks through pathophysiology, presentation, diagnosis, and management with a focus on high-yield exam points.

---

Pathophysiology of Hypothyroidism

Hypothyroidism is defined as **deficient synthesis or release of thyroid hormones**, leading to decreased circulating **thyroxine (T4)** and **triiodothyronine (T3)**. The result is **slowed metabolic processes** throughout the body.

Thyroid Axis Overview (Step 1 Focus)

Understanding the feedback relationships in the **hypothalamic–pituitary–thyroid (HPT) axis** is essential:

• **Hypothalamus** secretes **TRH (thyrotropin-releasing hormone)**.
• TRH stimulates the **anterior pituitary** to release **TSH (thyroid-stimulating hormone)**.
• TSH stimulates the **thyroid gland** to produce and release **T4 and T3**.
• Circulating T4/T3 exert **negative feedback** on both the pituitary and hypothalamus.

In hypothyroidism, disruption can occur at any of these three levels:

• **Primary hypothyroidism**: intrinsic failure of the thyroid gland.
• **Secondary hypothyroidism**: pituitary deficiency of TSH.
• **Tertiary hypothyroidism**: hypothalamic deficiency of TRH.

Levels of Dysfunction and Typical Lab Patterns

A core Step 1 and Step 2 CK skill is recognizing lab patterns that localize the defect.

| Level of dysfunction | TSH | Free T4 | Typical causes | |----------------------|-----|---------|----------------| | **Primary** | ↑ | ↓ | Hashimoto thyroiditis, iodine deficiency, thyroidectomy, radioiodine ablation, drugs (amiodarone, lithium) | | **Secondary** | ↓ | ↓ | Pituitary tumor, Sheehan syndrome, pituitary surgery | | **Tertiary** | ↓ (due to ↓TRH) | ↓ | Hypothalamic injury, infiltrative disease |

**Key pattern recognition:**

• **Primary hypothyroidism**: **↑TSH, ↓Free T4**.
• **Central (secondary/tertiary) hypothyroidism**: **↓TSH, ↓Free T4**.

Hashimoto Thyroiditis (Step 1 Focus)

In iodine-sufficient regions, the **most common cause of primary hypothyroidism** is **Hashimoto thyroiditis**, an autoimmune process.

High-yield features:

• Associated with **anti-thyroid peroxidase (anti-TPO)** antibodies.
• Associated with **anti-thyroglobulin** antibodies.

These autoantibodies are frequently tested as markers of autoimmune thyroid destruction.

Systemic Effects of Low Thyroid Hormone

Thyroid hormone normally:

• Acts via **nuclear receptors**.
• **Increases basal metabolic rate**.
• **Increases β-adrenergic receptor expression**.

When thyroid hormone levels fall:

• Metabolic rate slows → **fatigue, weight gain, cold intolerance**.
• Reduced β-adrenergic activity contributes to **bradycardia** and other cardiovascular changes.

These mechanisms explain the broad clinical manifestations seen in hypothyroidism.

---

Clinical Presentation of Hypothyroidism

Symptoms of hypothyroidism typically develop **gradually** as metabolic activity slows. On USMLE vignettes, look for a constellation of systemic findings rather than a single symptom.

Common Symptoms and Signs

• **Fatigue and lethargy** – patients often describe low energy and decreased activity.
• **Cold intolerance** – feeling unusually cold in normal environments.
• **Weight gain despite decreased appetite** – slowed metabolism with reduced caloric intake.
• **Constipation** – due to decreased gut motility.
• **Dry, coarse skin and hair loss** – classic integumentary changes.
• **Bradycardia** – slower heart rate from decreased β-adrenergic receptor expression.
• **Delayed deep tendon reflexes** – especially a **delayed relaxation phase**.
• **Menstrual irregularities and infertility** – reproductive axis disruption.
• **Nonpitting edema (myxedema)** – due to **glycosaminoglycan accumulation** in interstitial tissues.

Cardiovascular and Metabolic Effects (Step 2 CK Focus)

Hypothyroidism can cause:

• **Reversible hypercholesterolemia** – important as a secondary cause of elevated cholesterol.
• **Secondary hypertension** – due to **increased peripheral resistance**.

Recognizing hypothyroidism as an underlying cause of these findings is a common Step 2 CK theme.

Severe Form: Myxedema Coma

**Myxedema coma** is a **life-threatening decompensation** of severe hypothyroidism.

Key features:

• **Hypothermia**.
• **Hypoventilation**.
• **Hypotension**.
• **Altered mental status**.
• Often **precipitated by infection or sedatives**.

On exams, an elderly patient with known or suspected hypothyroidism who becomes obtunded, cold, and hypotensive after an infection or sedative exposure should immediately raise concern for myxedema coma.

---

Diagnostic Approach to Hypothyroidism

Initial Laboratory Evaluation

The **first-line tests** in suspected hypothyroidism are:

• **Serum TSH**.
• **Free T4**.

Interpretation:

• **Primary hypothyroidism**: **↑TSH, ↓Free T4**.
• **Central (secondary/tertiary) hypothyroidism**: **↓TSH, ↓Free T4**.

This distinction is critical for both Step 1 and Step 2 CK.

Additional Testing

Depending on the clinical context, further evaluation may include:

• **Thyroid autoantibodies**:
• **Anti-thyroid peroxidase (anti-TPO)**.
• **Anti-thyroglobulin**.
• Helpful for identifying **autoimmune causes** such as Hashimoto thyroiditis.

• **Thyroid ultrasound**:
• Used to assess for **nodules**.
• Can show **atrophy** of the gland in chronic disease.

• **Imaging of the pituitary/hypothalamus**:
• Indicated when **central hypothyroidism** is suspected (low TSH and low free T4).
• Helps identify **pituitary tumors**, **Sheehan syndrome** sequelae, or **hypothalamic injury/infiltrative disease**.

Etiologic Clues from History

While the exam may not always require you to name every cause, recognizing patterns is high-yield:

• **Primary hypothyroidism** etiologies:
• **Hashimoto thyroiditis**.
• **Iodine deficiency**.
• **Thyroidectomy**.
• **Radioiodine ablation**.
• **Drugs**: **amiodarone**, **lithium**.

• **Secondary hypothyroidism** etiologies:
• **Pituitary tumor**.
• **Sheehan syndrome**.
• **Pituitary surgery**.

• **Tertiary hypothyroidism** etiologies:
• **Hypothalamic injury**.
• **Infiltrative disease**.

On Step 2 CK, vignettes often embed these clues in the past medical or surgical history.

---

Management and Prevention

Thyroid Hormone Replacement

The **mainstay of therapy** for hypothyroidism is **levothyroxine**, a synthetic form of **T4**.

Key principles:

• Dose is **titrated to normalize**:
• **Serum TSH** in **primary hypothyroidism**.
• **Free T4** in **central hypothyroidism** (since TSH is not reliable when the pituitary is abnormal).

• **Start lower doses** in:
• **Elderly patients**.
• **Patients with cardiac disease**.

This is to avoid **precipitating angina or arrhythmias** due to sudden increases in metabolic demand and β-adrenergic sensitivity.

Monitoring Therapy

• **Monitor TSH every 6–8 weeks** until the dose is stable.
• Once stable, **check annually**.
• Adjust the dose if other medications interfere with absorption, including:
• **Iron**.
• **Calcium**.
• **Proton pump inhibitors (PPIs)**.

These interactions are frequently tested as subtle dose-adjustment questions on Step 2 CK.

Myxedema Coma Management (Step 2 CK Focus)

**Myxedema coma** is an emergency.

• Requires **IV levothyroxine**.
• Requires **supportive care** (e.g., hemodynamic and respiratory support).
• Therapy is often **initiated empirically** when clinical suspicion is high, without waiting for confirmatory labs.

Recognizing when to **start treatment immediately** is a key Step 2 CK competency.

Drug-Induced vs. Autoimmune Hypothyroidism

On exams, you may need to distinguish between **drug-induced** and **autoimmune** causes:

• **Drug-induced hypothyroidism**:
• Common culprits: **amiodarone**, **lithium**.
• History of these medications is a major clue.

• **Autoimmune hypothyroidism (Hashimoto)**:
• Associated with **anti-TPO** and **anti-thyroglobulin** antibodies.

Both ultimately lead to the same treatment—**levothyroxine**—but the underlying cause may guide additional management decisions.

---

High-Yield Differentials & Pitfalls

While the source material focuses on hypothyroidism, exam questions often test your ability to differentiate it from related conditions or avoid common reasoning errors.

Differentiating Primary vs. Central Hypothyroidism

| Feature | Primary hypothyroidism | Central hypothyroidism (secondary/tertiary) | |--------|------------------------|---------------------------------------------| | TSH | **High** | **Low** | | Free T4| **Low** | **Low** | | Site of defect | Thyroid gland | Pituitary (secondary) or hypothalamus (tertiary) | | Monitoring therapy | TSH | Free T4 |

**Pitfall:** Treating central hypothyroidism and using **TSH** to guide dosing. In central disease, TSH is not a reliable marker; **free T4** should be used.

Myxedema vs. Myxedema Coma

• **Myxedema**: refers to **nonpitting edema** due to **glycosaminoglycan accumulation** in tissues; seen in chronic hypothyroidism.
• **Myxedema coma**: a **severe, life-threatening** state with **hypothermia, hypoventilation, hypotension, and altered mental status**, often triggered by **infection or sedatives**.

**Pitfall:** Assuming “coma” is required for the diagnosis. On exams, **altered mental status** plus systemic decompensation in a hypothyroid patient is enough to suspect myxedema coma.

Overlooking Secondary Effects

• **Hypercholesterolemia** and **secondary hypertension** may be the presenting features.
• Failure to consider hypothyroidism as an underlying cause is a common diagnostic oversight.

On Step 2 CK, a patient with new hypercholesterolemia or increased peripheral resistance should prompt you to consider screening for hypothyroidism.

---

Exam Vignette with Stepwise Reasoning

**Vignette:**

A 68-year-old woman is brought to the emergency department in winter after being found confused and difficult to arouse. She has a history of long-standing fatigue, constipation, and weight gain despite poor appetite. Medications include a sedative she started 3 days ago for insomnia. On exam, she is lethargic, with a temperature of 34°C (93.2°F), blood pressure 80/50 mm Hg, respiratory rate 8/min, and pulse 48/min. Her skin is dry and coarse, and she has nonpitting edema of the face and extremities.

**Question:** What is the most appropriate immediate management?

**Stepwise reasoning:**

• Elderly woman with **chronic hypothyroid symptoms**: fatigue, constipation, weight gain, dry skin, nonpitting edema.
• Now presents with **hypothermia**, **hypotension**, **hypoventilation**, **bradycardia**, and **altered mental status**.
• Recent **sedative use** is a known **precipitating factor**.
• This constellation is classic for **myxedema coma**, a **life-threatening decompensation** of hypothyroidism.
• **Step 2 CK Focus**: Myxedema coma is an emergency requiring **IV levothyroxine and supportive care**, often initiated **empirically**.

**Correct management:** Initiate **IV levothyroxine** and provide **supportive care** (e.g., hemodynamic and respiratory support) immediately.

---

Key Takeaways

• **Hypothyroidism** is a state of **decreased thyroid hormone production or action**, leading to **slowed metabolic processes**.
• **Primary hypothyroidism**: **↑TSH, ↓Free T4**; most often due to **Hashimoto thyroiditis** in iodine-sufficient regions, with **anti-TPO** and **anti-thyroglobulin** antibodies.
• **Secondary/tertiary (central) hypothyroidism**: **↓TSH, ↓Free T4** due to pituitary or hypothalamic dysfunction.
• Classic symptoms: **fatigue, cold intolerance, weight gain with low appetite, constipation, dry coarse skin, hair loss, bradycardia, delayed reflex relaxation, menstrual irregularities, infertility, and nonpitting edema**.
• Hypothyroidism can cause **reversible hypercholesterolemia** and **secondary hypertension** from increased peripheral resistance.
• **Myxedema coma** presents with **hypothermia, hypoventilation, hypotension, and altered mental status**, often triggered by **infection or sedatives**, and requires **emergent IV levothyroxine and supportive care**.
• **Levothyroxine** is the treatment of choice; titrate to **TSH** in primary disease and **free T4** in central disease.
• Start **lower doses in elderly or cardiac patients** to avoid precipitating **angina or arrhythmias**; monitor TSH every **6–8 weeks** until stable, then **annually**.
• Adjust levothyroxine dosing when patients are on **iron, calcium, or PPIs**, which can alter absorption.

---

Keep Learning

Mastering hypothyroidism for **USMLE Step 1** and **Step 2 CK** means integrating endocrine physiology, lab interpretation, and clinical reasoning. As you continue studying, practice working through vignettes that require distinguishing primary from central hypothyroidism, recognizing autoimmune versus drug-induced causes, and identifying myxedema coma from subtle clues. For more structured practice and core concept reviews across systems, explore additional resources on /core-concepts and build spaced-repetition decks or question blocks tailored to endocrine disorders on /build.